Drug intelligence / Profile preview

ACE

Development stage: Unknown
Administration: Oral, Intravenous

Overview

The term 'ACE' is non-specific and refers to at least three distinct entities in the provided context: a medical device for total hip replacement (JRI Orthopaedics ACE Acetabular Cup System), a sound coding strategy for cochlear implants (ACE - Advanced Combination Encoder), and an herbal mixture of *Artemisia iwayomogi Kitamura* and *Curcuma longa Linne* used in traditional medicine for anti-atherosclerosis and hyperlipidemia effects.

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on ACE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACE.

Explore the full profile